Interesting how they managed to mention Corona in there.
The patent to be granted for Progenza also covers Acute Respiratory Distress Syndrome
(ARDS), an inflammatory lung condition identified as a cause of death among patients
diagnosed with COVID-191
- Forums
- ASX - By Stock
- CMB
- Ann: Regeneus to be granted new key Progenza patent in U.S.
Ann: Regeneus to be granted new key Progenza patent in U.S., page-3
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CMB (ASX) to my watchlist
|
|||||
Last
35.0¢ |
Change
-0.005(1.41%) |
Mkt cap ! $4.235M |
Open | High | Low | Value | Volume |
35.0¢ | 35.5¢ | 35.0¢ | $52 | 148 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1328 | 35.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
35.5¢ | 261 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1328 | 0.350 |
1 | 2500 | 0.200 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.355 | 261 | 1 |
0.415 | 904 | 1 |
0.420 | 1910 | 1 |
0.450 | 6000 | 1 |
0.500 | 2135 | 2 |
Last trade - 15.33pm 16/08/2024 (20 minute delay) ? |
Featured News
CMB (ASX) Chart |